What Is the Best Vancomycin Therapeutic Drug Monitoring Parameter to Assess Efficacy? A Critical Review of Experimental Data and Assessment of the Need for Individual Patient Minimum Inhibitory Concentration Value
Therapeutic drug monitoring is recommended for the use of vancomycin, but a recent widely publicized US medical society consensus statement has changed the suggested optimal method(s) of dose adjustment. Specifically, 24 h area under the curve (AUC<sub>24</sub>)-based monitoring is has b...
Main Author: | Bruce R. Dalton |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/11/3/567 |
Similar Items
-
Evaluation of vancomycin individualized model-based dosing approach in neonates
by: Manal Abouelkheir, et al.
Published: (2023-05-01) -
Clinical Application Value of Pharmacokinetic Parameters of Vancomycin in Children Treated in the Pediatric Intensive Care Unit
by: Bo Zhou, et al.
Published: (2022-06-01) -
Vancomycin and daptomycin dosing recommendations in patients receiving home hemodialysis using Monte Carlo simulation
by: Susan J. Lewis, et al.
Published: (2023-09-01) -
Daptomycin area under the curve to minimum inhibitory concentration ratio by broth microdilution for predicting the outcome of vancomycin-resistant Enterococcus bloodstream infection
by: Yu-Chung Chuang, et al.
Published: (2022-11-01) -
Daily vancomycin dose requirements as a continuous infusion in obese versus non-obese SICU patients
by: Hsin Lin, et al.
Published: (2016-07-01)